Furthermore, downregulation of ANO1 reduces PI3K/Akt phosphorylation, inhibiting ovarian cancer cell growth by disrupting the PI3K/Akt signaling pathway (168). The gene discussed is AKT1; the disease is ovarian carcinoma.